IDiyas

For the Inventor, By the Inventor

Leverkusen, Germany

Hans-Joachim Kabbe

USPTO Granted Patents = 34

Average Co-Inventor Count = 3.0

ph-index = 12

Forward Citations = 388(Granted Patents)


Company Filing History:

goldMedal34 out of 12,157 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1976-1995

Loading Chart...
34 patents (USPTO):Explore Patents
1. 5459143 - N,N-disubstituted piperazines (1995-10-17),
2. 5411960 - Substituted pyrroloanthracenes and -diones (1995-05-02),
3. 5409932 - Piperazine-substituted pyrroloanthracenes (1995-04-25),
4. 5221681 - Substituted benzoxazepines and benzothiazepines (1993-06-22),
5. 4980343 - Aminooxodihydroisoindoloquinazoline carcinostatic agents (1990-12-25),
6. 4757072 - Carcinostatic agent (1988-07-12),
7. 4659737 - Substituted aminomethyl benzopyrans having anti-hypertensive activities (1987-04-21),
8. 4647579 - Circulation active novel substituted 4-hydroxy-benzopyrans (1987-03-03),
9. 4644000 - Microbicidal agents containing 2-(1H-pyrazol-1-yl)-4-(3H)-quinazolinones (1987-02-17),
10. 4622339 - Novel norbornane- and norbornene-carboxylic acid amides thromboxan (1986-11-11),
11. 4574124 - Lipid absorption-inhibiting agents and their use (1986-03-04),
12. 4563458 - Substituted 4-aminomethylene-chromans and -chromenes, processes for (1986-01-07),
13. 4510156 - Bisindolyl alkylene ureas lipid absorption-inhibiting agents and their (1985-04-09),
14. 4479007 - Chroman-4-ones and process for preparing same (1984-10-23),
15. 4466964 - Lipid absorption-inhibiting 1,4-benzothiazines (1984-08-21),

Title: The Innovative Journey of Hans-Joachim Kabbe

Introduction:

Hans-Joachim Kabbe, a dedicated inventor hailing from Leverkusen, DE, has become a prominent figure in the world of inventors due to his relentless pursuit of innovation and excellence. Through his work, he continues to inspire future generations to explore the realms of technology and sustainability.

Latest Patents:

With an impressive portfolio of 33 patents, Hans-Joachim Kabbe has made significant contributions to the field of medicine and immunomodulation. His latest patents include the development of N,N-disubstituted piperazines and substituted pyrroloanthracenes and -diones. These compounds serve as essential active agents in medicaments, particularly in the production of immunomodulators.

Career Highlights:

Hans-Joachim Kabbe's career is marked by a series of groundbreaking inventions that have reshaped the landscape of pharmaceuticals. Working at Bayer Aktiengesellschaft, he has consistently pushed the boundaries of scientific exploration and technological advancement. His innovative spirit and dedication to excellence have established him as a thought leader in his field.

Collaborations:

Throughout his career, Hans-Joachim Kabbe has collaborated with esteemed colleagues such as Rudiger Sitt and Arno Widdig. Together, they have combined their expertise to drive forward cutting-edge research and development in the pharmaceutical industry. These collaborations have led to the creation of groundbreaking solutions that have had a lasting impact on the field of medicine.

Conclusion:

In conclusion, Hans-Joachim Kabbe's unwavering commitment to innovation and his passion for pushing the boundaries of what is possible have solidified his position as a respected inventor. His contributions to the world of inventors serve as a testament to the power of dedication, perseverance, and creativity in driving meaningful change and advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…